Back to search
FDAFDA · Food and drugs·Recall number D-0041-2027

Sermorelin, 1 mg/mL, 10 ml vial, Sterile injectable solution, RX Only, Houston RX LLC, 15430 Vantage Parkway E STE 220, Houston, TX 77032.

Published October 21, 2026 · Recall initiated: September 25, 2026

Summary

FDA records drug Class II recall D-0041-2027, published October 21, 2026 and initiated September 25, 2026. Recalling firm: Houston Rx LLC; Status: Ongoing; Reported quantity: 7 vials; Lot: Lot# SER-081726-1-10, Beyond Use Date: 10/01/2026. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of process control

What to do

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Houston Rx LLC
Distributor
Nationwide in the USA.
Lot
Lot# SER-081726-1-10, Beyond Use Date: 10/01/2026.
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Sermorelin, 1 mg/mL, 10 ml vial, Sterile injectable solution, RX Only, Houston RX LLC, 15430 Vantage Parkway E STE 220, Houston, TX 77032. recalled?

Yes. FDA published recall D-0041-2027 on October 21, 2026. Reported hazard: Lack of process control

What should I do if I have this product?

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit